Seven Bridge Financial Group, LLC Crispr Therapeutics Ag Transaction History
Seven Bridge Financial Group, LLC
- $552 Million
- Q3 2024
A detailed history of Seven Bridge Financial Group, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Seven Bridge Financial Group, LLC holds 6,076 shares of CRSP stock, worth $333,329. This represents 0.05% of its overall portfolio holdings.
Number of Shares
6,076
Previous 5,651
7.52%
Holding current value
$333,329
Previous $305,000
6.56%
% of portfolio
0.05%
Previous 0.07%
Shares
11 transactions
Others Institutions Holding CRSP
# of Institutions
503Shares Held
57MCall Options Held
1.7MPut Options Held
1.8M-
Capital International Investors Los Angeles, CA7.87MShares$431 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$411 Million3.35% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$163 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$163 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$152 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.28B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....